Tag: COVID-19

NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients

February 5, 2021

A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…


Breaking News: Novartis Temporarily Modifies U.S. Mobile Administration Program for Sandostatin LAR During Pandemic

April 8, 2020

Due to the COVID-19 pandemic and Novartis’ ongoing commitment to support patients,  Novartis has temporarily modified the eligibility criteria related to their U.S. mobile administration program (MAP) to allow for use by patients currently receiving…